Birdwatch Note
2024-09-23 20:21:08 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Project 2025 suggests a doctor's visit to access the abortion pill. The complication rate of Mifepristone is 5.2%. The greater the gestational age, the higher the risk. Seeing a doctor before taking the medication can help avoid potential life-threatening complications static.project2025.org https://www.aafp.org/pubs/afp/issues/2022/0100/p5.html
Written by DD8AA3A7743E7D212AA3E029ABFB5BDB57CC839ACFB9C6E8625A1C94CCDC9419
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1838236328472834244
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1838312667418890303
- noteId - 1838312667418890303
- participantId -
- noteAuthorParticipantId - DD8AA3A7743E7D212AA3E029ABFB5BDB57CC839ACFB9C6E8625A1C94CCDC9419
- createdAtMillis - 1727122868767
- tweetId - 1838236328472834244
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Project 2025 suggests a doctor's visit to access the abortion pill. The complication rate of Mifepristone is 5.2%. The greater the gestational age, the higher the risk. Seeing a doctor before taking the medication can help avoid potential life-threatening complications static.project2025.org https://www.aafp.org/pubs/afp/issues/2022/0100/p5.html
Note Ratings
| rated at | rated by | |
| 2024-09-30 12:27:56 -0500 | Rating Details | |
| 2024-09-26 22:54:18 -0500 | Rating Details | |
| 2024-09-26 00:16:41 -0500 | Rating Details | |
| 2024-09-24 13:32:25 -0500 | Rating Details | |
| 2024-09-24 12:51:50 -0500 | Rating Details | |
| 2024-09-24 08:56:33 -0500 | Rating Details | |
| 2024-09-24 08:27:25 -0500 | Rating Details | |
| 2024-09-24 07:28:32 -0500 | Rating Details | |
| 2024-09-24 07:19:21 -0500 | Rating Details | |
| 2024-09-24 07:12:42 -0500 | Rating Details | |
| 2024-09-24 07:09:00 -0500 | Rating Details | |
| 2024-09-24 06:23:15 -0500 | Rating Details | |
| 2024-09-24 05:39:27 -0500 | Rating Details | |
| 2024-09-24 05:15:00 -0500 | Rating Details | |
| 2024-09-24 04:34:06 -0500 | Rating Details | |
| 2024-09-24 04:22:29 -0500 | Rating Details | |
| 2024-09-24 01:16:41 -0500 | Rating Details | |
| 2024-09-24 00:51:43 -0500 | Rating Details | |
| 2024-09-24 00:21:32 -0500 | Rating Details | |
| 2024-09-24 00:09:27 -0500 | Rating Details | |
| 2024-09-23 23:43:10 -0500 | Rating Details | |
| 2024-09-23 23:02:37 -0500 | Rating Details | |
| 2024-09-23 23:00:10 -0500 | Rating Details | |
| 2024-09-23 22:34:13 -0500 | Rating Details | |
| 2024-09-23 22:07:57 -0500 | Rating Details | |
| 2024-09-23 19:40:57 -0500 | Rating Details | |
| 2024-09-23 19:26:58 -0500 | Rating Details | |
| 2024-09-23 19:19:04 -0500 | Rating Details | |
| 2024-09-23 17:54:58 -0500 | Rating Details | |
| 2024-09-23 16:58:46 -0500 | Rating Details | |
| 2024-09-23 16:55:05 -0500 | Rating Details | |
| 2024-09-23 16:41:40 -0500 | Rating Details | |
| 2024-09-23 16:34:03 -0500 | Rating Details | |
| 2024-09-23 16:32:03 -0500 | Rating Details | |
| 2024-09-23 16:25:09 -0500 | Rating Details | |
| 2024-09-23 16:08:50 -0500 | Rating Details | |
| 2024-09-23 15:29:14 -0500 | Rating Details |